Effect of Probiotics on Functional Constipation in Adults
- Disease/Condition
- Functional Constipation
- Drug/Device/Intervention
- Placebo
- Study type
- Interventional
- Intervention type
- dietary supplement
- Primary sponsor
- Luciane Cruz Lopes
- Funder
- University of Sorocaba
- Location
- Sorocaba, Brazil
- Phase
- N/A
- Start date
- Mar 11, 2020
- End date
- Jan 28, 2021
- Enrollment
- 150 participants
Changed in the number of Bowel movements. Changed for more than 3 per week was considered a clinical response.,Change in the Bristol stool form scale at 4 weeks after Probiotics. Recovery to types 3-4 was considered a clinical response.
Introduction:
 
 Functional constipation is a symptom-based gastrointestinal disorder without an organic
 origin (eg, bowel obstruction). It has a prevalence of 14% in adults.
 
 Objective:
 
 The objective of trial is to evaluate the efficacy and safety of two different probiotic
 blends in adults subjects with functional constipation.
 
 Methods:
 
 A double-blind, randomized, placebo-controlled study will be conducted for up to two years to
 evaluate the efficacy of two different probiotic mixtures: (Mixture 1) Lactobacillus
 acidophilus, Bifidobacterium bifidum and Lactobacillus rhamnosus (3 billion CFU); (Mixture 2)
 Lactobacillus acidophilus, Bifidobacterium bifidum, Lactobacillus rhamnosus, Lactobacillus
 paracasei, Bifidobacterium longum, Bifidobacterium lactis, Lactobacillus defensis,
 Bifidobacterium animallis (8 billion CFU).
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT04437147
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT04437147 through Pure Global AI's free database. This phase not specified trial is sponsored by Luciane Cruz Lopes and is currently Completed. The study focuses on Functional Constipation. Target enrollment is 150 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.